|
2025
|
P/S
|
Pharmaceutical preparations and gene therapy products in the nature of injectable biological prep... |
|
|
P/S
|
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations and gene therapy products in the
nature of injectable biologic prepa... |
|
|
P/S
|
Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à sa... |
|
|
P/S
|
providing an internet website portal offering the sale of products in the field of health and med... |
|
2024
|
Invention
|
Ribociclib tablet.
The present disclosure is directed to oral tablet of ribociclib including its... |
|
|
Invention
|
Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide poly... |
|
|
P/S
|
Logiciels téléchargeables pour la fourniture d'informations médicales et pharmaceutiques aux pati... |
|
|
P/S
|
Downloadable software for use in providing medical and pharmaceutical information for patients; d... |
|
|
P/S
|
Downloadable software for use in providing medical and
pharmaceutical information for patients; ... |
|
|
P/S
|
Dietary and nutritional supplements; vitamins. |
|
|
Invention
|
Means and method for preparing viral vectors and uses of same.
Methods for preparing and purifyi... |
|
|
P/S
|
Services de conseils en affaires dans le domaine de la mise en place, de la pratique et du foncti... |
|
|
P/S
|
Business consulting services in the field involving the implementation, practice and operation of... |
|
|
Invention
|
Antibody drug conjugates for ablating hematopoietic stem cells.
The present invention provides a... |
|
|
Invention
|
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof.
The present... |
|
|
Invention
|
S1p modulator immediate release dosage regimen.
The present invention relates to siponimod (BAB3... |
|
|
Invention
|
Methods of treating dry eye disease using tnf alpha antagonists.
The disclosure is directed to n... |
|
|
Invention
|
Treatment of hidradenitis suppurativa using anti-baff-r antibodies. The disclosure relates to met... |
|
|
Invention
|
Extended dosing regimens for anti-cd20 antibodies in the treatment of multiple sclerosis. The dis... |
|
|
Invention
|
Covalent targeting of e3 ligases.
Disclosed herein, inter alia, are compositions and methods for... |
|
|
Invention
|
Bispecific antibodies for use in lowering the risk of cardiovascular disease events in subjects k... |
|
|
Invention
|
Nlrp3 inhibitor for use in lowering the risk of cardiovascular diseases. The present disclosure r... |
|
|
Invention
|
Complement factor b inhibitors and uses thereof. Provided herein are compounds of Formula (I) and... |
|
|
Invention
|
Method of treating cancer. The present disclosure relates to a method of treating well-differenti... |
|
|
Invention
|
Method of treating cancer.
The present disclosure relates to a method of treating well-different... |
|
|
Invention
|
Methods of using factor b inhibitors. Described herein are methods of treating gMG (generalized M... |
|
|
Invention
|
Fap targeting cyclic peptides and conjugates thereof.
Described herein are cyclic peptides targe... |
|
|
Invention
|
Immunosuppressant formulations.
The present invention relates to a solid phase pharmaceutical co... |
|
|
Invention
|
Fap targeting cyclic peptides and conjugates thereof. Described herein are cyclic peptides target... |
|
|
Invention
|
Compounds and compositions for modulating the activity of erk.
The invention relates to compound... |
|
|
Invention
|
Compounds and compositions for modulating the activity of erk. The invention relates to compounds... |
|
|
Invention
|
Antiviral 1,3-di-oxo-indene compounds.
This disclosure provides compounds of Formula (I)
This ... |
|
|
Invention
|
Compositions and methods of use for therapeutic antibodies.
The present invention relates to ant... |
|
|
Invention
|
New uses of omalizumab. 150mg/mL omalizumab formulation for use in a method of treatment of one o... |
|
|
Invention
|
Polyomavirus neutralizing antibodies.
The present invention relates to anti-VP1 antibodies, anti... |
|
|
Invention
|
10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridaz... |
|
|
Invention
|
Antibody molecules to pd-1 and uses thereof.
Antibody molecules that specifically bind to PD-1 a... |
|
|
Invention
|
Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and... |
|
|
Invention
|
Digital solutions for differentiating asthma from copd.
The present disclosure relates generally... |
|
|
Invention
|
Compositions and methods to treat cancer.
The disclosure provides novel personalized therapies, ... |
|
|
Invention
|
Factor xi antibodies and methods of use.
The present disclosure relates to monoclonal antibodies... |
|
|
Invention
|
Interleukin-17 (il-17) antagonistic antibodies.
An Interleukin-17 (IL-17) binding molecule, in p... |
|
|
Invention
|
Il-18 binding molecules.
IL-18 participates in both innate and acquired immunity. The bioactivit... |
|
|
Invention
|
Methods of treating non-radiographic axial spondyloarthritis using interleukin-17 (il-17) antagon... |
|
|
Invention
|
Immunosuppressant formulation.
The present invention concerns a dosage form, preferably for imme... |
|
2023
|
Invention
|
Tetrahydro-pyrido-pyrimidine derivatives.
The invention relates to substituted tetrahydro-pyrido... |
|
|
Invention
|
Compositions and methods for immunooncology.
The present disclosure is directed to genome editin... |
|
|
Invention
|
Remibrutinib for use in the treatment of hidradenitis suppurativa.
The present disclosure relate... |
|
|
Invention
|
Stable and soluble antibodies inhibiting vegf.
The present invention relates to soluble and stab... |
|
|
Invention
|
Process for the synthesis of pyrazolyl derivatives useful as anti-cancer agents.
The invention p... |
|
|
Invention
|
Ribociclib pharmaceutical compositions.
Disclosed are pharmaceutical formulations containing 7-c... |
|
|
Invention
|
Spirocyclic piperidinyl derivatives as complement factor b inhibitors and uses thereof.
Provided... |
|
|
Invention
|
Tlr7/8-antagonist for treating sjögren's syndrome or mixed connective tissue disease.
The presen... |
|
2022
|
Invention
|
Pyridine-3-carboxylate compounds as cav1.2 activators.
The present disclosure provides for a com... |
|
|
Invention
|
Methods of treatment using lou064.
The present disclosure relates to methods of treating and/or ... |
|
|
Invention
|
Compounds and compositions for the treatment of coronaviral related diseases.
Provided herein ar... |
|
|
Invention
|
Dosing regimen for an nlrp3 inhibitor in the treatment of osteoarthritis.
The present disclosure... |
|
|
Invention
|
Compositions and methods for the treatment of hemoglobinopathies.
The present invention is direc... |
|
2019
|
Invention
|
Novel dosing regimens for mdm2 inhibitors.
The present invention relates to the HDM2-p53 interac... |
